Terry Vance, Director at ENANTA PHARMACEUTICALS INC (ENTA), bought 13,295 shares at $14.00 ($186K) on 2013-03-26, disclosed to the SEC on 2013-03-28.
Open-market purchase of $186k ENTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |